Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...
Hosted on MSN6mon
Why the weight-loss drug boom is just the beginning
Fuelled by blockbuster marvels like Ozempic and Mounjaro, which were developed ... including Wegovy and Zepound. Pharma giants Novo Nordisk and Eli Lilly are leading the charge with these game ...
Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines
Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.